Star Health & Allied Insurance Company Ltd is Rated Hold

Current Rating and Its Significance

The 'Hold' rating assigned to Star Health & Allied Insurance Company Ltd indicates a balanced view of the stock’s prospects. It suggests that investors should maintain their existing positions rather than aggressively buying or selling at this time. This recommendation is based on a comprehensive analysis of four key parameters: Quality, Valuation, Financial Trend, and Technicals. Each of these factors contributes to the overall assessment of the stock’s potential risk and reward profile.

Quality Assessment

As of 26 September 2026, Star Health & Allied Insurance exhibits an average quality grade. The company demonstrates strong long-term fundamental strength, particularly evident in its operating profit growth. Operating profits have grown at a compound annual growth rate (CAGR) of 19.64%, signalling robust operational efficiency and profitability over time. However, this strength is tempered by a concerning decline in net sales, which have contracted at an annual rate of -48.82%. This divergence suggests that while the company is managing costs and improving margins, top-line growth remains a challenge.

Valuation Considerations

The valuation grade for Star Health & Allied Insurance is classified as very expensive. The stock currently trades at a price-to-book (P/B) ratio of 4.3, which is a significant premium compared to its peers’ historical averages. This elevated valuation reflects high investor expectations for future growth and profitability. Despite the premium, the company’s return on equity (ROE) stands at a moderate 11.1%, which may not fully justify the lofty valuation. Additionally, the price-to-earnings-to-growth (PEG) ratio is 3.8, indicating that the stock’s price growth outpaces its earnings growth, a factor that investors should weigh carefully.

Financial Trend and Recent Performance

Financially, the company shows a positive trend. The latest quarterly results for June 2026 highlight significant improvements: profit before tax less other income (PBT less OI) reached ₹749.21 crores, growing by 287.7% compared to the previous four-quarter average. Net sales for the quarter hit a record high of ₹5,522.07 crores, while profit before depreciation, interest, and taxes (PBDIT) also peaked at ₹749.21 crores. These figures underscore a strong operational quarter, which supports the current 'Hold' rating by demonstrating the company’s ability to generate profits despite broader sales challenges.

Technical Analysis

From a technical perspective, the stock is mildly bullish. Recent price movements show resilience, with a one-day gain of 1.32% and a one-week increase of 1.89%. Although the stock has experienced some short-term volatility, including a 4.48% decline over the past month and a 3.50% drop over three months, it has delivered a robust 21.42% return over six months and a 22.45% year-to-date gain. Over the past year, the stock has generated a 22.38% return, outperforming the broader BSE500 index, which declined by 2.22% during the same period. This market-beating performance reflects positive investor sentiment and technical strength.

Institutional Confidence

Institutional investors hold a significant 35.45% stake in Star Health & Allied Insurance, indicating confidence from knowledgeable market participants. These investors typically have greater resources and expertise to analyse company fundamentals, lending credibility to the stock’s current valuation and outlook. Their involvement can provide stability and support for the stock price, especially during periods of market uncertainty.

Summary of Current Position

In summary, Star Health & Allied Insurance Company Ltd’s 'Hold' rating reflects a nuanced view of its prospects. The company benefits from strong operational profitability and positive financial trends, but faces challenges in sustaining top-line growth and justifying its premium valuation. The mildly bullish technical outlook and solid institutional backing further support a cautious stance. Investors should consider these factors carefully when deciding whether to maintain their holdings or await clearer signals before increasing exposure.

Investor Takeaway

For investors, the 'Hold' rating suggests maintaining current positions while monitoring the company’s ability to address its sales growth challenges and justify its valuation premium. The strong quarterly earnings and market-beating returns provide reasons for optimism, but the elevated price multiples and average quality grade counsel caution. Investors seeking exposure to the insurance sector may find Star Health & Allied Insurance a balanced choice, offering growth potential tempered by valuation risks.

Market Context and Outlook

Within the broader insurance sector, Star Health & Allied Insurance stands out for its operational improvements and institutional support. However, the sector’s competitive dynamics and regulatory environment require ongoing vigilance. The company’s ability to sustain profit growth and improve sales will be critical to upgrading its rating in the future. Meanwhile, the current 'Hold' rating reflects a prudent approach, balancing the positives against the risks inherent in its valuation and sales trajectory.

Performance Metrics at a Glance (As of 26 September 2026)

- Market Capitalisation: Smallcap
- Mojo Score: 57.0 (Hold)
- 1 Day Return: +1.32%
- 1 Week Return: +1.89%
- 1 Month Return: -4.48%
- 3 Month Return: -3.50%
- 6 Month Return: +21.42%
- Year-to-Date Return: +22.45%
- 1 Year Return: +22.38%
- Price to Book Value: 4.3
- Return on Equity: 11.1%
- PEG Ratio: 3.8
- Institutional Holdings: 35.45%

These metrics provide a comprehensive snapshot of the stock’s current standing, helping investors make informed decisions based on the latest available data.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →